235
Conclusion:
This retrospective population study demonstrates an
insight into the demographics and fracture patterns in facial trauma
patients.
http://dx.doi.org/10.1016/j.ijom.2017.02.792Mandibular distraction osteogenesis preceding
interpositional arthoplasty — a novel protocol in
management of temporomandibular joint ankylosis
M.J. Raghani
∗
, B. Pappachan
All India Institute of Medical Sciences (AIIMS), Raipur, India
Background:
Temporomandibular joint (TMJ) ankylosis leads to
a significant amount of facial deformity in the affected individuals,
more so in adult patients with long-standing bony union. Cor-
rection of facial deformity by distraction osteogenesis has now
become a mainstay for the treatment of craniofacial syndromes
with mandibular hypoplasia including TMJ ankylosis. There is an
increased risk of reankylosis when the facial deformity due to TMJ
ankylosis is attempted to be corrected by the distraction osteoge-
nesis after release of ankylotic mass. To overcome this potential
problem we have attempted the correction of facial deformity by
distraction prior to release of ankylosis.
Objectives of this study:
To evaluate the benefits of distraction
osteogenesis prior to release of TMJ ankylosis.
Methods:
50 patients of TMJ ankylosis were treated using our pro-
tocol i.e. distraction first and then ankylosis release subsequently.
Patients included in this study were aged between 5 and 50 years.
Both extraoral and intraoral distractors were used depending on
the requirement and socioeconomic status of the patient. Minimum
follow-up period was 6 months.
Findings and Conclusion:
The combination of correction of
facial deformity as the primary procedure and ankylosis release
as secondary procedure provides good functional and aesthetic
results in patients with facial deformity due to TMJ ankylosis.
http://dx.doi.org/10.1016/j.ijom.2017.02.793Effectiveness of vitamin b complex in reducing chronic
temporomandibular joint disorder pain — double blind
randomised clinical trial
J.R. Rajaran
∗
, W.S. Choi
The University of Hong Kong, Hong Kong
Background:
Chronic temporomandibular joint disorder (TMD)
pain management has always been challenging and usually
requires long-term analgesics. Commonly used analgesics have
a potential for adverse effects in long-term usage, thus there is a
need to look for a safer alternative analgesic option.
Objectives:
To evaluate efficacy of vitamin B complex (VBC)
[B1, B6, B12] in reducing chronic TMD pain.
Methods:
26 patients with chronic TMD pain secondary to
arthralgia, osteoarthritis and disc displacement were included. The
patients were allocated randomly into two groups and received
either VBC tablet (B1: 242.5 mg, B6: 250 mg, B12: 1 mg) or
placebo once per day for six weeks. Clinical measurements were
recorded at week 0 and week 2, week 4, and week 6 to evalu-
ate the efficacy of the treatment. Pain intensity was measured by
visual analogue score (VAS) and mandibular range of movement
was measured by maximal comfortable mandibular opening and
lateral excursion. Adverse effects and compliance rate towards
treatment were also assessed.
Findings:
In this 6-week clinical trial, both groups showed signif-
icant VAS pain reduction (VBC 2.49
±
1.71; placebo 1.41
±
1.53;
P
< 0.05). The amount of VAS pain reduction in the VBC group
was significantly higher than in the Placebo group at week 2
(1.19
±
1.28 versus 0.23
±
0.90) and week 4 (2.32
±
1.42 versus
1.25
±
0.75;
P
< 0.05). No statistically significant difference was
noted in mouth opening improvement. Both VBC and placebo
medications were well tolerated with minimal adverse effects.
Conclusion:
In this study a dose of VBC (B1: 242.5 mg, B6:
250 mg, B12: 1 mg) was significantly better than placebo in reduc-
ing chronic TMD pain at week two and week four.
http://dx.doi.org/10.1016/j.ijom.2017.02.794Frequency and morbidity of temporomandibular joint
involvement in adult patients with a history of juvenile
idiopathic arthritis
C. Resnick
∗
, R. Dang, L. Henderson, D. Zander, K. Daniels,
P. Nigrovic, L. Kaban
Boston Children’s Hospital, Boston, MA, United States
Background:
The majority of patients with juvenile idiopathic
arthritis (JIA) have involvement of the temporomandibular joints
(TMJs), but little is known about the natural history of TMJ disease
as these children enter into adulthood.
Objective:
To evaluate adults with a history of JIA in order to
document the frequency and severity of TMJ abnormalities and
TMJ-related morbidity.
Methods:
This is a cross-sectional study including adult patients
with JIAwho were managed at Boston Children’s Hospital as chil-
dren and at Brigham and Women’s Hospital as adults. Subjects
completed a study questionnaire, physical examination and max-
illofacial cone-beam CT (CBCT). Additional data was obtained
from medical records. We examined the associations between
our primary outcome variable: TMJ abnormality on CBCT,
and components of the arthritis history, arthritis severity, den-
tal/orthodontic history, TMJ pain, maximal incisal opening (MIO),
facial asymmetry, physical examination findings and cephalomet-
ric analysis.
Findings:
21 subjects (42 TMJs) with mean age 26.06.1 years and
a mean duration of care for JIA in our institution of 13.76.5 years
were enrolled. 62% had TMJ pain, 43% had functional limita-
tion, and 76% had lower facial asymmetry. TMJ abnormalities
were found on 55% of CBCTs, with 79% bilateral. 81% had
one cephalometric measurement relating to mandibular size or
position >1 standard deviation from normal.
Conclusion:
TMJ abnormalities and related morbidity are com-
mon in adult patients with a history of JIA. Therefore, an early
screening protocol for TMJ involvement may be sensible and
long-term follow-up in to adulthood is necessary.
http://dx.doi.org/10.1016/j.ijom.2017.02.795




